: Polycystic ovary syndrome (PCOS) is a common endocrine disorder associated with various cardiometabolic risk factors, including insulin resistance, dyslipidemia, hypertension, and obesity, which contribute to an increased risk of cardiovascular diseases. This inaugural systematic review and meta-analysis of randomized controlled trials (RCTs) evaluated the impact of magnesium supplementation on various cardiometabolic risk factors and hormonal parameters in patients with polycystic ovary syndrome (PCOS). : We systematically searched the MEDLINE, Web of Science, Scopus, and Cochrane databases until 30 March 2024 for studies comparing magnesium supplementation to control in improving cardiometabolic and hormonal factors in PCOS patients. Endpoints were summarized as mean differences (MD) and 95% confidence intervals (CIs) in a random-effects model. : The primary search yielded 176 studies. After screening, six studies met our inclusion criteria. Our meta-analysis showed no significant effects of magnesium supplementation on cardiometabolic risk factors and hormonal parameters in patients with PCOS. : Magnesium supplementation does not appear to influence the cardiometabolic and hormonal factors in PCOS patients. Further rigorous RCTs are needed to strengthen the evidence and support comprehensive analysis in this area. PROSPERO database (CRD42024526110).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11857371 | PMC |
| http://dx.doi.org/10.3390/medicina61020280 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association between female cardiometabolic index and infertility: a population-based study.
Front Public Health
March 2025
Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Background: Visceral fat accumulation and dyslipidaemia are associated with infertility symptoms. The cardiometabolic index (CMI) is a comprehensive quantitative measure of central obesity and dyslipidaemia. However, the link between the female CMI and the couple infertility needs to be explored further.
View Article and Find Full Text PDFAdditive association of blood group A allele with 15 cardiometabolic diseases: a UK Biobank life-course study.
Cardiovasc Diabetol
March 2025
School of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
Background: Although existing studies have reported associations between blood group A and cardiometabolic diseases (CMD), most have focused on dominant inheritance models. However, genome-wide association studies have mostly been based on additive genotypes. This study aims to investigate the association between the blood group A allele and 15 CMD using recessive, dominant, and additive models and identify potential mediators.
View Article and Find Full Text PDFSex-specific socioeconomic inequalities in trajectories of anthropometry, blood pressure, and blood-based biomarkers from birth to 18 years: a prospective cohort study.
Eur J Public Health
March 2025
School of Public Health, University College Cork, Cork, Ireland.
Evidence on when socioeconomic inequalities in conventional cardiometabolic risk factors emerge and how these change over time is sparse but important in identifying pathways to socioeconomic inequalities in cardiovascular disease (CVD). We examine socioeconomic inequalities in cardiometabolic risk factors trajectories across childhood and adolescence. Data were from the Avon Longitudinal Study of Parents and Children (ALSPAC), born in 1991/1992.
View Article and Find Full Text PDFMarkers of fitness, stress, and cardiometabolic disease risk among law enforcement officers.
J Occup Environ Med
February 2025
ALERRT Center, Texas State University, San Marcos, TX 78666.
Objective: Law enforcement officers (LEOs) face numerous stressors that exacerbate cardiometabolic disease (CMD) risk. The current study examined novel and classic risk factors among a cohort of LEOs to better understand relationships between biomarkers of stress, oxidative stress, inflammation, and CMD risk.
Methods: Associations between measures of cardiorespiratory and muscular fitness, body composition, and cardiometabolic health with novel/classic CMD risk factors were assessed among 66 male LEOs.
Effect of Oral Semaglutide Versus Comparators on Multiple Cardiometabolic Risk Factor Control in Adults With Type 2 Diabetes.
Diabetes Care
March 2025
Leicester Diabetes Centre, Diabetes Research Centre, Leicester General Hospital, Leicester, U.K.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!